It has been increasingly recognized that FABP4 dysfunction is associated with various metabolic syndromes, including obesity, diabetes, cardiovascular diseases, and metabolic inflammation. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.